Restoration of bacterial killing activity of human respiratory cystic fibrosis cells through cationic vector-mediated cystic fibrosis transmembrane conductance regulator gene transferBIFFI, A; SERSALE, G; CASSETTI, A et al.Human gene therapy. 1999, Vol 10, Num 12, pp 1923-1930, issn 1043-0342Article

Cell therapy : achievements and perspectivesBORDIGNON, C; CARLO-STELLA, C; TURA, S et al.Haematologica (Roma). 1999, Vol 84, Num 12, pp 1110-1149, issn 0390-6078Article

Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transferMAVILIO, F; FERRARI, G; ROSSINI, S et al.Blood. 1994, Vol 83, Num 7, pp 1988-1997, issn 0006-4971Article

Hematopoietic histoincompatibility reaction by NK cells in vitro: model for genetic resistance to marrow graftsBORDIGNON, C; DALEY, J. P; NAKAMURA, I et al.Science (Washington, D.C.). 1985, Vol 230, Num 4732, pp 1398-1401, issn 0036-8075Article

Human monomuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acidVICENZI, E; BIONDI, A; BORDIGNON, C et al.Clinical and experimental immunology (Print). 1984, Vol 57, Num 2, pp 385-392, issn 0009-9104Article

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinomaSANTORO, A; PRESSIANI, T; COLOMBI, S et al.British journal of cancer. 2010, Vol 103, Num 6, pp 837-844, issn 0007-0920, 8 p.Article

A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs diseaseMARTINO, S; MARCONI, P; MANSERVIGI, R et al.Human molecular genetics (Print). 2005, Vol 14, Num 15, pp 2113-2123, issn 0964-6906, 11 p.Article

Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulinFALQUI, L; MARTINENGHI, S; POZZA, G et al.Human gene therapy. 1999, Vol 10, Num 11, pp 1753-1762, issn 1043-0342Article

An in vivo model of somatic cell gene therapy for human severe combined immunodeficiencyFERRARI, G; ROSSINI, S; GIAVAZZI, R et al.Science (Washington, D.C.). 1991, Vol 251, Num 4999, pp 1363-1366, issn 0036-8075, 4 p.Article

Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transferKANTOFF, P. W; GILLIO, A. P; KARLSSON, S et al.The Journal of experimental medicine. 1987, Vol 166, Num 1, pp 219-234, issn 0022-1007Article

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapiesMAMMOLITI, S; ANDRETTA, V; MAZZOLA, G et al.Annals of oncology. 2011, Vol 22, Num 4, pp 973-978, issn 0923-7534, 6 p.Article

Progress and prospects: graft-versus-host diseaseMASTAGLIO, S; STANGHELLINI, Mtl; BORDIGNON, C et al.Gene therapy (Basingstoke). 2010, Vol 17, Num 11, pp 1309-1317, issn 0969-7128, 9 p.Article

Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal modelMARTINE, S; CAVALIERI, C; ORLACCHIO, A et al.Neurochemical research. 2002, Vol 27, Num 7-8, pp 793-800, issn 0364-3190, 8 p.Article

Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungsBRAGONZI, A; DINA, G; VILLA, A et al.Gene therapy (Basingstoke). 2000, Vol 7, Num 20, pp 1753-1760, issn 0969-7128Article

The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytesFLEISCHHAUER, K; GATTINONI, L; DALERBA, P et al.Cancer research (Baltimore). 1998, Vol 58, Num 14, pp 2969-2972, issn 0008-5472Article

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemiaBONINI, C; FERRARI, G; BORDIGNON, C et al.Science (Washington, D.C.). 1997, Vol 276, Num 5319, pp 1719-1724, issn 0036-8075Article

Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3FLEISCHHAUER, K; FRUCI, D; VAN ENDERT, P et al.International journal of cancer. 1996, Vol 68, Num 5, pp 622-628, issn 0020-7136Article

NATURAL CYTOTOXICITY ON TUMOUR CELLS OF HUMAN MACROPHAGES OBTAINED FROM DIVERSE ANATOMICAL SITESMANTOVANI A; BAR SHAVIT Z; PERI G et al.1980; CLIN. EXPER. IMMUNOL.; GBR; DA. 1980; VOL. 39; NO 3; PP. 776-784; BIBL. 29 REF.Article

NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cellsDI MATTEO, P; HACKL, C; JEDESZKO, C et al.British journal of cancer. 2013, Vol 109, Num 2, pp 360-369, issn 0007-0920, 10 p.Article

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patientsLORUSSO, D; SCAMBIA, G; MANTORI, M et al.British journal of cancer. 2012, Vol 107, Num 1, pp 37-42, issn 0007-0920, 6 p.Article

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumoursGREGORC, V; SANTORO, A; BENNICELLI, E et al.British journal of cancer. 2009, Vol 101, Num 2, pp 219-224, issn 0007-0920, 6 p.Article

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA^- immunodeficient patientsBORDIGNON, C; NOTARANGELO, L. D; UGAZIO, A. G et al.Science (Washington, D.C.). 1995, Vol 270, Num 5235, pp 470-475, issn 0036-8075Article

Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tractBRAGA, M; GIANOTTI, L; VIGNALI, A et al.British journal of surgery. 1995, Vol 82, Num 12, pp 1637-1640, issn 0007-1323Article

Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functionsFERRARI, G; ROSSINI, S; NOBILI, N et al.Blood. 1992, Vol 80, Num 5, pp 1120-1124, issn 0006-4971Article

Page / 2